Gerhard Bauer, B.S. for UC Davis Health

Gerhard Bauer, B.S.

Adjunct Professor

Laboratory Director, Good Manufacturing Practice Facility




Internal Medicine


Internal Medicine

Locations and Contact

UC Davis Institute for Regenerative Cures (IRC)

UC Davis Institute for Regenerative Cures (IRC)
2921 Stockton Blvd.
Sacramento, CA 95817

Get Directions

Research/Academic Interests

Gerhard Bauer is an assistant professor of hematology and oncology and director of the Good Manufacturing Practice (GMP) laboratory at the UC Davis Institute for Regenerative Cures. In addition to GMP design and construction expertise, Bauer also has extensive experience in the field of gene and cell therapy, having spent two decades developing novel clinical applications to improve medical outcomes for life-threatening illnesses.

He also has investigated potential therapies for HIV, replacing the devastated immune system of an HIV-infected patient with cells that have been engineered to resist the virus. Bauer came to the UC Davis Health System in 2006 after designing and directing a state-of-the-art GMP laboratory at Washington University in St. Louis.


Hematology and Oncology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center

Undergraduate School

B.S., Laboratory Sciences, Educational Eval for the U.S. (Foundation for International Studies), Seattle WA 1990

Editor-in-Chief, Molecular Therapy-Methods and Clinical Development, 2019, 2020, 2021, 2022, 2023, 2024

Dean's Team Award for Excellence-Electronic Medical Records Task Force, 2013

Dean's Team Award for Excellence in Research, UC Davis, 2010

Appreciation Award, UC Davis, 2009

For a comprehensive list of Dr. Bauer's publications, please click here .

Abou-El-Enein M, Angelis A, Appelbaum FR, Andrews NC, Bates SE, Bierman AS, Brenner MK, Cavazzana M, Caligiuri MA, Clevers H, Cooke E, Daley GQ, Dzau VJ, Ellis LM, Fineberg HV, Goldstein LSB, Gottschalk S, Hamburg MA, Ingber DE, Kohn DB, Krainer AR, Maus MV, Marks P, Mummery CL, Pettigrew RI, Rutter JL, Teichmann SA, Terzic A, Urnov FD, Williams DA, Wolchok JD, Lawler M, Turtle CJ, Bauer G, Ioannidis JPA. Evidence generation and reproducibility in cell and gene therapy research: A call to action. Mol Ther Methods Clin Dev. 2021 Jul 21;22:11-14. doi:10.1016/j.omtm.2021.06.012. PMID:34377737.

Belafsky P, Clayton SM, Archard JA, Pavlic JP, Rao S, Farwell DG, Kuhn M, Deng P, Halmai J, Bauer G, Fink KD, Fury B, Perotti NH, Walker JE, Beliveau AM, Birkeland A, Abouyared M, Cary W, Nolta JA, Anderson JD. Model of radiation-induced ambulatory dysfunction. J Medical Sciences (Taiwan). 2021;41(4):201-210. doi:10.4103/jmedsci.jmedsci_259_20.

SC4HD Consortium. Stem Cells for Huntington's Disease (SC4HD): An International Consortium to Facilitate Stem Cell-Based Therapy for Huntington's Disease. J Huntingtons Dis. 2021;10(2):221-226. doi:10.3233/JHD-210473. PMID:33814456.

Fury B, Klassen H, Bauer G. Manufacturing of Clinical Grade Cellular Products Under GMP Conditions. Zarbin MA, Singh MS, Casaroli-Marano RP (eds). Cell-Based Therapy for Degenerative Retinal Diseases, Springer Nature Switzerland AG, Cham. 2019;5:81-95.

Yuan O, Lin C, Wagner J, Archard JA, Deng P, Halmai J, Bauer G, Fink KD, Fury B, Perotti NH, Walker JE, Pollock K, Apperson M, Butters J, Belafsky P, Farwell DG, Kuhn M, Nolta J, Anderson JD. Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion. Stem Cells Dev. 2019 Mar 15;28(6):398-409. doi:10.1089/scd.2018.0200. Epub 2019 Feb 26. PMID:30638129.

Fierro FA, Magner N, Beegle J, Dahlenburg H, Logan White J, Zhou P, Pepper K, Fury B, Coleal-Bergum DP, Bauer G, Gruenloh W, Annett G, Pifer C, Nolta JA. Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions. Transfusion. 2019 Feb;59(S1):893-897. doi:10.1111/trf.14914. Epub 2018 Nov 1. PMID:30383901.

Bauer G, Elsallab M, Abou-El-Enein M. Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions. Stem Cells Transl Med. 2018 Sep;7(9):676-685. doi:10.1002/sctm.17-0282. Epub 2018 Jul 31. PMID:30063299.

Holley SM, Kamdjou T, Reidling JC, Fury B, Coleal-Bergum D, Bauer G, Thompson LM, Levine MS, Cepeda C. Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings. CNS Neurosci Ther. 2018 Apr;24(4):329-342. doi:10.1111/cns.12839. Epub 2018 Mar 6. PMID:29512295.

Reidling JC, Relaño-Ginés A, Holley SM, Ochaba J, Moore C, Fury B, Lau A, Tran AH, Yeung S, Salamati D, Zhu C, Hatami A, Cepeda C, Barry JA, Kamdjou T, King A, Coleal-Bergum D, Franich NR, LaFerla FM, Steffan JS, Blurton-Jones M, Meshul CK, Bauer G, Levine, MS, Chesselet, MF, Thompson, LM. Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice. Stem Cell Reports. 2018 Jan 9;10(1):58-72. doi:10.1016/j.stemcr.2017.11.005. Epub 2017 Dec 7. PMID:29233555.